Researchers decipher when and why T cells become non-responsive to immunotherapy
Non-small cell lung cancer (NSCLC) is the most common type of lung cancer in humans. Some patients with NSCLC receive
Read moreNon-small cell lung cancer (NSCLC) is the most common type of lung cancer in humans. Some patients with NSCLC receive
Read moreOne way messenger RNA (mRNA) vaccines provide robust protection against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is by
Read moreAs vaccination programs around the globe are beginning to slow, the transmission of coronavirus 2019 (COVID-19) has risen again, with
Read moreJapanese scientists created “elite” antibodies that defeat various coronavirus variants even at an extremely low dose through a new method
Read moreThe severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has mutated since its initial emergence in Wuhan, China, in late 2019.
Read moreA treatment combining two antibodies (casirivimab and imdevimab) is recommended for two specific groups of patients with covid-19 by a
Read moreNew research from the University of Virginia School of Medicine quantifies the antibody response generated by the Pfizer and Moderna
Read moreWhen the Food and Drug Administration announced last week that a third dose of Moderna or Pfizer-BioNTech covid-19 vaccine may
Read moreA recent study conducted at the Medical University of Graz, Austria, has revealed that the number of naïve B cells
Read moreThe Faculty of Medicine, Chulalongkorn University has brought out a quick, inexpensive, and easy-to-use leptospirosis test strip kit to help
Read more